These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 14647960

  • 21. Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.
    Heekeren K, Daumann J, Geyer MA, Gouzoulis-Mayfrank E.
    Psychopharmacology (Berl); 2004 May; 173(3-4):418-24. PubMed ID: 14722707
    [Abstract] [Full Text] [Related]

  • 22. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
    McCann UD, Peterson SC, Ricaurte GA.
    Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011
    [Abstract] [Full Text] [Related]

  • 23. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A.
    Rev Neurol; 2007 Aug; 41(2):108-14. PubMed ID: 16028190
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
    Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL.
    Neuropsychopharmacology; 2011 May; 36(6):1127-41. PubMed ID: 21326196
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI, Hoshi R, Talbot AC.
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [Abstract] [Full Text] [Related]

  • 29. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K.
    J Psychopharmacol; 1998 Mar; 12(1):79-83. PubMed ID: 9584971
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Preliminary evidence of hippocampal damage in chronic users of ecstasy.
    den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L.
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):83-5. PubMed ID: 21444322
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
    Hanson KL, Luciana M.
    Psychol Med; 2004 Feb; 34(2):229-46. PubMed ID: 14982129
    [Abstract] [Full Text] [Related]

  • 40. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
    Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E.
    Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.